Thus, according to current research, approaches suppressing ZBTB20 activity or expression will rescue the disturbed PTEN/PI3K-Akt signaling and alleviate OA symptoms, providing a promising lead for osteoarthritis treatment. Here, AKT1 is linked to osteoarthritis.